Advanced search
Publication Cover
HIV Clinical Trials Volume 11, 2010 - Issue 5
Submit an article Journal homepage
39
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Similar Virologic and Immunologic Efficacy With Fosamprenavir Boosted With 100 mg or 200 mg of Ritonavir in HIV-Infected Patients: Results of the LESS Trial

Calvin CohenCommunity Research Initiative of New England Boston, Massachusetts, USA
,
Edwin DeJesusOrlando Immunology Center Orlando, Florida, USA
,
Anthony LaMarcaTherafirst Medical Center Fort Lauderdale, Florida, USA
,
Benjamin YoungUniversity of Colorado, Denver, Colorado, USA
,
Linda YauGlaxoSmithKline Research Triangle Park, North Carolina, USA
,
Lisa PatelGlaxoSmithKline Research Triangle Park, North Carolina, USA
,
Cindy VavroGlaxoSmithKline Research Triangle Park, North Carolina, USA
,
Mary Beth WireGlaxoSmithKline Research Triangle Park, North Carolina, USA
,
Paul WannamakerGlaxoSmithKline Research Triangle Park, North Carolina, USA
&
Mark ShaeferGlaxoSmithKline Research Triangle Park, North Carolina, USACorrespondence[email protected]
 show all
Pages 239-247 | Published online: 06 Jan 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

B. Ha, B. Wine, F. Rodriguez-Alcantra & M. Shaefer. (2012) Hepatic Safety Profile of Fosamprenavir-Containing Regimens in HIV-1–Infected Patients With or Without Hepatitis B or C Coinfection. HIV Clinical Trials 13:3, pages 171-177.
Read now

Articles from other publishers (3)

Dushyantha T. Jayaweera & Gary E. Pakes. (2012) Virologic and Lipoprotein Changes after Halving Ritonavir Boosting in HIV-Infected Patients Stabilized on Once-Daily Fosamprenavir plus Abacavir/Lamivudine. World Journal of AIDS 02:02, pages 109-116.
Crossref
Franco Felizarta, Anthony Scarsella, Homayoon Khanlou, Winston Young, Lisa Ross, Henry Zhao, Keith Pappa & Belinda Ha. (2012) Impact of Switch to Fosamprenavir and Addition of Lovaza<sup>&#174;</sup> for Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy. World Journal of AIDS 02:01, pages 24-32.
Crossref
Cecilia Pizzocolo, Antonella Castagna & Adriano Lazzarin. (2011) HIV protease inhibitors: present and future. Future Virology 6:5, pages 571-580.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.